Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Current Drug Shortages E - K

 

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov.  Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

A  B  C  D  [E– K]  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Edetate Calcium Disodium (Calcium Disodium Versenate) Injection (Initial Posting Date) – 10/12/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Medicis Pharmaceutical Corporation:
1-800-900-6389
 		500 mg ampoules   (NDC 99207-240-10)Product available under limited distribution.
Medicis is currently in the process of securing a new manufacturer.		Dear Healthcare Professional Letter (PDF - 86KB) regarding Expiry Extension for Lot 0503.

Other
 

 

 

Epinephrine Injection (Initial Posting Date) – 4/27/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747		1:10,000; 10 mL Abboject-1 ½ “ needle(NDC 0409-4921-34)

Next delivery late June

Estimated recovery 4Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Manufacturing delays

Other

Revised 6/14/2013
1:10,000; 10 mL Abboject-3 ½ “ needle (NDC 0409-4901-18)

Next delivery late June

Estimated recovery June

Amphastar Pharmaceuticals, Inc./IMS
Customer Service:
1-800-423-4136

1:10,000, 10mL Luer-Jet Prefilled Syringe

 

NDC 76329-3316-1

(old NDC 0548-3316-00)		Amphastar will regularly release products.

Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.

Shortage by Manufacturer:
Increased Demand

Demand increase for the drugReverified 5/28/2013

 

Epinephrine 1mg/mL (Preservative Free) (Initial posting-6/21/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747		1 mg/mL, 1 mL ampule, preservative-free (contains sulfite), package of 25 (NDC 00409-7241-01)

Next delivery mid June
Estimated recovery 3Q 2013

Manufacturing delay:
Manufacturing delay 		Other

Revised 6/14/2013

JHP Pharma
1-877-547-4548		Adrenalin (epinephrine injection, USP)
1 mg/mL, 1 mL vial, (contains sulfite) pack of 25 
(NDC 42023-122-25)
 		Available  Reverified 6/11/2013
American Regent/Luitpold
1-800-645-1706

30 mL vial, package of 5 (NDC 00517-1130-05)

Unavailable

American Regent is currently not releasing the preserved 30 mL vial

Shortage per Manufacturer: Manufacturing delay
 

 

OtherRevised 6/18/2013 
1 mg/mL, 1 mL ampule, preservative free, sulfite-free,
package of 25 (NDC 00517-1071-25)		Estimate release end of July 2013

 

Ethiodol (Ethiodized Oil) Ampules

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Guerbet LLC
Customer Service
(1-877-729-6679)		 Guerbet has acquired the Ethiodol NDA from Nycomed US Inc. effective May 7, 2010 and is working with FDA to resume manufacturing of Ethiodol in the near future to ensure continued availability for the US patients.

During this interim period, Guerbet, in conjunction with the FDA, is initiating a temporary importation of LIPIODOL ULTRA-FLUIDE, ethyl esters of iodized fatty acids of poppy seed oil, to the United States market.

See Dear Healthcare Professional Letter (PDF - 483KB) for additional information.
(Letter updated 3/20/2012)

Shortage per Manufacturer:
Product has been discontinued by Nycomed US Inc. 

Discontinuation of the manufacture of the drug.Revised 3/16/2012

 

Etomidate (Amidate) Injection (Initial Posting Date) - 2/9/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated

Sagent Pharmaceuticals

1-866-625-1618

2 mg/mL 10 mL vial (NDC 25021-0674-10)
 

Available

 Delay in shipping of the drug. Demand increase for the drug.Reverified 6/3/2013

2 mg/mL 20 mL vial (NDC 25021-0674-20)

American Regent/Luitpold
1-800-645-1706		2 mg/mL vial
10 mL vial (NDC 00517-0780-10)		Unavailable

 

American Regent is currently not releasing the 10 mL or the 20 mL vial size of Etomidate Injection.
 

OtherReverified 6/18/2013
20 mL vial (NDC 00517-0781-10)Unavailable
 
Hospira Inc.
Customer Service
1-877-946-7747		2 mg/mL; 10 mL vial (NDC 0409-6695-01)

Next delivery mid June

Estimated recovery: June

Please check with your wholesaler for available inventory. 

 

Shortage per Manufacturer:
Manufacturing Delay

 

Other

Revised 6/14/2013
2 mg/mL; 20 mL vial (NDC 0409-6695-02)Next delivery late June
Estimated recovery: June
2 mg/mL; 20 mL Abboject syringe (NDC 0409-8060-29)

Next delivery late June
Estimated recovery: June

 

2 mg/mL; 20 mL amp (NDC 0409-8061-01)

Next delivery TBD

Estimated recovery: TBD

2 mg/mL; 10 mL amp (NDC 0409-8062-01)

Available

Bedford Customer Service:
1-800-562-4797		2 mg/mL injection
10 mL vial
(NDC 55390-0762-10)		Etomidate injection is on back order with no estimated date of availability.Shortage per Manufacturer:
Manufacturing Delay
 		Discontinuation of the manufacture of the drug. 
20 mL
(NDC 55390-0763-20)
Pfizer
Customer Service:
Pfizer Injectables
1-800-533-4535		20 mg/10ml injection (NDC 0069-0006-01)

Available

 

 

Reverified 6/6/2013

 

40 mg/20ml injection (NDC 0069-0006-03)

Mylan  Institutional 1-888-258-4199

2mg/mL, 20ml, 10s (NDC 67457-183-20)

Available

 Demand increase for the drug. Reverified 6/5/2013
2mg/mL, 10mL, 10s
(NDC 67457-183-10)
 

 

Fentanyl Citrate (Sublimaze) Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747		0.05 mg/mL; 2 mL Carpuject
(0409-1276-32)

Next delivery late 3Q 2013
Estimated recovery 4Q 2013

Carpuject orders (NDC 0409-1276-32) must be ordered through the wholesaler; check with your wholesaler regarding product allocation. It is recommended that the user institute fentanyl sparing strategies.

Shortage per Manufacturer:
Manufacturing delay/Available
 

Other

Revised 6/14/2013

0.05 mg/mL; 2 mL amp
(0409-9093-32)

Next delivery mid June

Estimated recovery 3Q 2013

0.05 mg/mL; 5 mL amp
(0409-9093-35)

Next delivery mid June

Estimated recovery 3Q 2013

0.05 mg/mL; 20 mL amp
(0409-9093-38)

Next delivery mid July
Estimated recovery 3Q 2013

0.05 mg/mL; 2 mL vial
(0409-9094-22)

Next delivery June
Estimated recovery June

0.05 mg/mL; 5 mL vial
(0409-9094-25)

Next delivery early July
Estimated recovery 3Q 2013

0.05 mg/mL; 10 mL vial
(0409-9094-28)

Available

0.05 mg/mL; 20 mL vial
(0409-9094-31)

Next delivery early July

Estimated recovery 3Q 2013

0.05 mg/mL; 50 mL vial
(0409-9094-61)

Next delivery late June

Estimated recovery 3Q 2013
 

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
 

50 mcg/mL

2 mL ampul
(NDC 0641-6024-10)

West-Ward has limited quantities available for the majority Fentanyl presentations.
 

There is currently a backorder on the 2 mL, 20 ml and 50 mL vials.
 

Additional lots of all presentation are scheduled for manufacturing with anticipated released and available in the February-March 2013 timeframe.
 

West-Ward has continued to accelerate production on all codes
 

 

 

Shortage per Manufacturer:
Increase in product demand due to market supply issues.
 

Product will be made available as it is released. 

 

Demand increase for the drug.

Revised 2/11/2013

50 mcg/mL

5 mL ampul

(NDC 0641-6025-10)

50 mcg/mL

20 mL ampul

(NDC 0641-6026-05)

50 mcg/mL

2 mL vial

(NDC 0641-6027-25)

50 mcg/mL

5 mL vial

(NDC 0641-6028-25)

50 mcg/mL

20 mL vial

(NDC 0641-6029-25)

50 mcg/mL

 50 mL vial

(NDC 0641-6030-01)

Akorn Pharmaceuticals
1-800-932-5676		2 mL ampule (NDC 17478-0030-02)Readily available

 NA

 NA

Reverified 4/3/2013

2 mL ampule; 25 pack (NDC 17478-0030-25)

5 mL ample (NDC 17478-0030-05)
20 mL ample (NDC 17478-0030-20)

 

Fluphenazine Decanoate Injection (Initial Posting Date)- 4/25/2013

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated

APP

1-888-386-1300

125 mg, 5mL, multi-dose vial (NDC 63323-272-05)

Currently back-ordered. Check wholesalers for inventory.  Next release anticipated Q3-2013.

 

Shortage per Manufacturer:  Manufacturing delay due to raw material delays

Shortage of an active ingredient Reverified 6/5/2013
 

 

Fluphenazine Hydrochloride Injection (Initial Posting Date)- 4/29/2013

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated

APP

1-888-386-1300


25 mg, 10 mL, multi-dose vial

(NDC 633323-281-10)

7 months dating available through manufacturer (expiry 11/30/2013) for direct or drop shipment.  Next release anticipated late May. 

7 months dating available

 

Shortage per Manufacturer:  Manufacturing delay due to raw material delays

Shortage of an active ingredient Reverified 6/5/2013
 

 

Fluticasone Propionate and Salmeterol (Advair HFA) Inhalation Aerosol (Initial Posting Date)- 10/17/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
GlaxoSmithKline
Customer Service:
1-888-825-5249
 

ADVAIR HFA 45/21mcg

(NDC# 0173-0715-20 &
0173-0715-22)
 

Out-of-Stock

Resupply expected
4Q 2013
 

All other strengths remain available.  

Shortage per Manufacturer: 
Manufacturing Delays
 		Revised 5/28/2013
 

 

Fosphenytoin Sodium (Cerebyx) Injection (Initial posting 3/30/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira, Inc.
Customer Service
1-877-946-7747		75 mg/mL; 2 mL vial (NDC 0409-4857-02)Production of both presentations is temporarily suspended.Shortage per Manufacturer:
Temporarily suspended production.
 		Discontinuation of the manufacture of the drug.Reverified 6/14/2013
75 mg/mL; 10 mL vial (NDC 0409-4857-10
APP
Customer Service
1-888-386-1300		NDC # 63323-403-02 (100 mg PE/2 mL, 2 mL vial)Next delivery expected June 2013

All presentations currently back-ordered.  Check wholesalers for available inventory.
 

Shortage per Manufacturer:
Increase in Demand
 

 

Demand increase for the drug.Revised 6/5/2013
NDC # 63323-403-10 (500 mg PE/10 mL, 10 mL vial)Next delivery expected June 2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174  

50 mg PE/mL
(PE = phenytoin sodium equivalents)

2 mL vial (NDC 0143-9788-25)West-Ward is currently experiencing a backorder situation on both presentations.At this time, West-Ward does not have a projected availability date. Manufacturing delaysRevised 1/17/2013
10 mL vial (NDC 0143-9782-10)

  

 Furosemide Injection (Initial posting-6/20/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira Inc. Customer Service:
1-877-946-7747		10 mg/mL; 10 mL Ansyr Syringe
(NDC 0409-1639-10)

Next delivery mid July

Estimated recovery: 3Q 2013

Please check with your wholesaler for available inventory. 

 

Increased demand for the drug.
 

Revised 6/14/2013
10 mg/mL; 4 mL Ansyr Syringe
(NDC 0409-9631-04)

Next delivery late July

Estimated recovery: 3Q 2013

10 mg/mL; 2mL vial
(NDC 0409-6102-02

Available

10 mg/mL; 4mL vial
(NDC 0409-6102-04)

Available

10 mg/mL;10mL vial
(NDC 0409-6102-10)

Next delivery early June

Estimated recovery 2Q 2013

APP
1-888-386-1300		20 mg/2 mL, SDV (NDC 63323-028-002)Backordered.  Next release anticipated Q3 2013.

All presentations currently back-ordered. Check wholesalers for available inventory.

Shortage per Manufacturer:
Increased demand.
 

Demand increase for the drug.Reverified 6/5/2013 
40 mg/4 mL, SDV (NDC 63323-028-004)Manufacturer allocating.  Next release anticipated Q3 2013.
100 mg/10 mL, SDV (NDC 63323-028-010) Back-ordered. No estimated delivery at this time.
American Regent/ Luitpold
1-800-645-1706		10 mg/mL 2 mL vial (NDC 00517-5702-25)Unavailable

American Regent is currently not releasing the 2 mL, 4 mL or 10 mL vial of Furosemide Injection, USP.
 

 

 

 

Other Reverified 6/18/2013 
10 mg/mL 4 mL vial (NDC 00517-5704-25)Unavailable
10 mg/mL 10 mL vial (NDC 00517-5710-25)Unavailable

 

Gabapentin Enacarbil (Horizant) ER Tablet (Initial Posting- 4/16/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated

XenoPort, Inc.

1-877-XENOPRT (1-877-936-6778)

Horizant (gabapentin enacarbil) Extended- Release Tablets
600 mg 

Available

Please check with your wholesaler for available inventory. Revised 5/24/2013 

 

Gallium Nitrate (Ganite) Injection (Initial Posting - 4/4/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Genta Incorporated
1-888-TO-GENTA)		 No estimated date of availability.Business decisionDiscontinuation of the manufacture of the drug.4/4/2012

 

Heparin Sodium Premixes (Initial Posting - 7/5/2012)

 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated

Hospira Inc. Customer Service:
1-877-946-7747

Heparin sodium 50 U/mL; 1mL in 2mL Vial (NDC 0409-2723-01)

Next delivery mid June

Estimated recovery 3Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Manufacturing delay
 

Other

Revised 6/14/2013

Heparin sodium 50 U/mL in 0.9% sodium chloride; 500 mL container
(NDC 0409-7620-03)

Next delivery early June

Estimated recovery 3Q 2013

Heparin sodium 50 U/mL in 0.45% sodium chloride; 250 mL container
(NDC 0409-7651-62)

Next delivery late June

Estimated recovery June

Heparin sodium 50 U/mL in 0.45% sodium chloride; 500 mL container
(NDC 0409-7651-03)

Next delivery and estimated recovery 2014

Heparin sodium 100 U/mL in 0.45% sodium chloride; 250 mL container (NDC 0409-7650-62)

Available

Heparin sodium 100 U/mL in 5% dextrose; 250 mL container
(NDC 0409-7793-62)

Next delivery early July

Estimated recovery 3Q 2013

Heparin sodium 50 U/mL in 5% dextrose; 250 mL container
(NDC 0409-7794-62)

Next delivery and estimated recovery June

Heparin sodium 40 U/mL in 5% dextrose; 500 mL container
(NDC 0409-7760-03)

Next delivery and estimated recovery 2014

Heparin sodium 50 U/mL in 5% dextrose; 500 mL container
(NDC 0409-7761-03)

Next delivery and estimated recovery 2014

  

 

Hydromorphone Hydrochloride (Dilaudid) Injection (Initial Posting-3/7/12)  

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747		1 mg/mL; 1 mL amp (NDC 0409-2552-01)Available

Please check with your wholesaler for available inventory.

 

Shortage per manufacturer: Available

 

Other

Reverified 6/14/2013

1 mg/mL; 1 mL iSecure (NDC 0409-1283-10)

Available

1 mg/mL; 1 mL Carpuject (NDC 0409-1283-31)

Available

2 mg/mL; 1 mL vial (NDC 0409-3365-01)

Available 

Product 2 mg/mL; 1 mL amp (NDC 0409-3356-01)Available
4mg/mL; 1mL Carpuject  (NDC 0409-1304-31)Available
2 mg/mL; 1 mL iSecure (NDC 0409-1312-10)Available 
2mg/mL; 1mL Carpuject (NDC 0409-1312-30)Available
10mg/mL; 1mL Vial (NDC 0409-2634-01)Available
10 mg/mL; 5 mL vial (NDC 0409-2634-05)Available
10 mg/mL; 50 mL vial (NDC 0409-2634-50)Available
Teva Pharmaceuticals
1-800-545-8800		10 mg/mL, 1 mL vials (NDC 00703-0110-03)Teva has all presentations available. N/A 

Reverified 5/29/2013

10 mg/mL, 5 mL vials (NDC 00703-0113-03)
10 mg/mL, 50 mL vials (NDC 00703-0118-01)
West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001		1 mL vial, 2 mg/mL
(NDC 0641-0121-25)

West-Ward currently has limited quantities of both presentations available.

West-Ward has continued to accelerate production on both codes.
Additional lots are scheduled for manufacturing with anticipated released and available in March 2013. 

Product will be made available as it is released

Shortage per Manufacturer:
Increase in product demand due to market supply issues
 

Demand increase for the drug.Revised  2/10/2013
20 mL vial, 2 mg/mL
(NDC 0641-2341-41)

Akorn Pharmaceuticals
1-800-932-5676


 


 

10 mg/mL, 1 mL ampules (NDC 17478-0540-01)Readily available NANA 



 

Reverified
4/3/2013

10 mg/mL, 5 mL ampules (NDC 17478-0540-05)Readily available
10 mg/mL, 50 mL vials (NDC 17478-0540-50)

Readily available

 

NA
 

Purdue Pharma, L.P.

Customer Service

800.877.5666

Dilaudid injection: 1 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0441-10)Available Demand increase for the drug 

Revised 4/5/2013

Dilaudid injection: 2 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0442-10)Available
Dilaudid injection: 2 mg/mL, 1 mL ampules, package of 25 (NDC 59011-0442-25)Available
Dilaudid injection: 4 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0444-10)Available
Dilaudid-HP injection
250 mg vial, powder for injection (NDC 59011-0446-25)		Available

Dilaudid-HP injection

10 mg/mL, 1 mL ampules (NDC 59011-0445-01)

Available

Dilaudid-HP injection

10 mg/mL, 5 mL ampules (NDC 59011-0445-05)

Available
Dilaudid-HP injection
10 mg/mL, 50 mL vials (NDC 59011-0445-50		Available

 

Hydromorphone Hydrochloride Tablets (Initial posting- 2/19/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Mallinckrodt Customer Service:
1-800-325-8888		2 mg tablets (NDC 00406-3243-01)

Product temporarily unavailable.  Expect availability by Summer 2013. 

Shortage per Manufacturer: Shortage of an active ingredient.
 

Shortage of an active ingredient.Reverified 5/29/2013 
4 mg tablets (NDC 00406-3244-01)
8 mg tablets (NDC 00406-3249-01)

 

Ibandronate Sodium (Boniva) Injection (Initial posting-6/6/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Genentech, Inc.
Customer Service:
1-800-551-2231		3 mg/mL (single use syringe)
Box of 1 (NDC 0004-0191-09

Current backlog at the US distribution center.  Date of next supply availability is to be determined.
 

 

Please check with an authorized Genentech distributor for product availability.
 

Shortage per Manufacturer:
Compliance issue with i.v. infusion set that is enclosed in product kit and supplied by a third-party vendor

OtherRevised 3/18/2013

 

Intravenous Fat Emulsion

For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition: http://www.nutritioncare.org/Professional_Resources/Information_to_Use_in_the_Event_of_an_Intravenous_Fat_Emulsion_Shortage/

disclaimer icon

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Hospira Inc. Customer Service:
1-877-946-7747		10%; 250 mL (NDC 0409-9790-02)Hospira continues to investigate manufacturing process improvements.Shortage per Manufacturer:
Quality improvement activities
 		Requirements related to complying with good manufacturing practices

Reverified 6/14/2013

10%; 500 mL (NDC 0409-9790-03)
20%; 250 mL (NDC 0409-9791-02)
20%; 500 mL (NDC 0409-9791-03)
30%; 500 mL (NDC 0409-6892-03)

Baxter (Intralipid Emulsion)
Customer Service:
(1-888-229-0001)

 

 

 

 

 

 

 

 

 

 


 


 
 

Intralipid 20% Emulsion, 100 mL (NDC 00338-0519-48)

 

 

Back-ordered

 

Baxter has the following Intralipid 20% emulsions on allocation and is working to increase production to meet US market demand.


All orders must be made directly with Baxter's Center for Service by calling 1-888-229-0001.

N/A 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Demand increase for the drug

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reverified 5/7/2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intralipid 20% Emulsion, 250 mL (NDC 00338-0519-02)

 

 

Intralipid 20% Emulsion, 500 mL (NDC 00338-0519-03)
Intralipid 20% Emulsion, 1000 mL (NDC 00338-0519-04)
Intralipid 30% Emulsion, 500 mL (NDC 00338-0520-03)

Intralipid 30% Emulsion Available

 

 

Isoniazid; Rifampin (Rifamate) Capsules (Initial Posting Date) – 3/15/2013

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated
Sanofi-aventis U.S. LLC
1-800-981-2491		Rifamate capsules containing 300 mg rifampin and 150 mg isoniazid
(NDC 0068-0509-60)
 

Available 

Available

Other

Revised 5/30/2013 

 

Ketorolac Tromethamine Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*		Date Updated

Bedford Customer Service
1-800-562-4797 

15 mg/mL 1 mL vial, 10 count (NDC 55390-0480-01)

Bedford has all presentations of ketorolac injection on back order and the company cannot estimate a release date

Shortage per Manufacturer:
Manufacturing delays
 		Discontinuation of the manufacture of the drug. 
30 mg/mL 1 mL vial, 10 count (NDC 55390-0481-01)
30 mg/mL 10 mL vial, 10 count (NDC 55390-0481-10)
American Regent/Luitpold
1-800-645-1706		15 mg/mL 1 mL vial, 25 count (NDC 00517-0601-25)UnavailableAmerican Regent/Luitpold has discontinued manufacturing Ketorolac Tromethamine Injection, USPDiscontinuation of the manufacture of the drug.

Reverified 6/18/2013

30 mg/mL 1 mL vial, 25 count (NDC 00517-0801-25)
30 mg/mL 2 mL vial for intramuscular use, 25 count (NDC 00517-0902-25)
Wockhardt
Customer Service:
1-800-346-6854

30 mg/mL 1 mL vial, 10 count (NDC 64679-0758-04)

Wockhardt is presently  experiencing intermittent releases throughout the month  Demand increase for the drug.

Revised 3/28/2013

30 mg/mL 1 mL vial, 25 count (NDC 64679-0758-01)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.
30 mg/mL 2 mL vial, 10 count (NDC 64679-0758-06)Wochkhardt has existing inventories and no backorder presently. Order via your wholesaler or distributor.Available 
30 mg/mL 2 mL vial, 25 count (NDC 64679-0758-02)Wochkhardt has existing inventories and no backorder presently. Order via your wholesaler or distributor.Available  
15 mg/mL 1 mL vial, 10 count (NDC 64679-0757-02)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.
15 mg/mL 1 mL vial, 25 count (NDC 64679-0757-01)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.

APP
1-888-386-1300   

15 mg/mL 1 mL vial, 25 count (NDC 63323-0161-01)Backordered. Next release anticipated July 2013.

Check wholesalers for inventory.

Demand increase for the drug. Revised 6/5/2013
30 mg/mL 1 mL vial, 25 count (NDC 63323-0162-01)Backordered. Next release anticipated July 2013.
30 mg/mL 2 mL vial for intramuscular injection, 25 count (NDC 63323-0162-02)Available.  Check wholesaler inventory.

Hospira, Inc.
Customer Service
1-877-946-7747

15 mg/mL; 1 mL vial
(NDC 0409-3793-01)

Next delivery mid June

Estimated recovery 3Q 2013

15 mg/mL; 1 mL Carpuject (NDC 0409-2288-31) and 30 mg/mL; 2 mL Carpuject
(NDC 0409-2287-61)  suspended production until 2013 due to manufacturing line prioritization.

 

Shortage per manufacturer: Manufacturing delay/Available

Demand increase for the drug/Other

Revised 6/14/2013

15 mg/mL; 1 mL Carpuject
(NDC 0409-2288-31)		Available
30 mg/mL; 1mL vial
(NDC 0409-3795-01)

Next delivery mid June

Estimated recovery 3Q 2013

30 mg/mL; 1 mL Carpuject
(NDC 0409-2287-31)		Available
30 mg/mL; 2 mL Carpuject
(NDC 0409-2287-61)

Next delivery mid June

Estimated recovery June

60 mg/mL; 2 ml vial
(NDC 0409-3796-01)

Next delivery mid June

Estimated recovery June

back to top of page

Current Drug Shortages Index

-
-